Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 28, 2022
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
Ben Hendrix Maintained (CHE) at Buy with Increased Target to $592 on, Apr 28th, 2022
Ben Hendrix of RBC Capital, Maintained "Chemed Corporation" (CHE) at Buy with Increased Target from $579 to $592 on, Apr 28th, 2022.
Ben has made no other calls on CHE in the last 4 months.
There is 1 other peer that has a rating on CHE. Out of the 1 peers that are also analyzing CHE, 0 agree with Ben's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ben
- Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $579 on, Friday, March 4th, 2022
